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The nicotinic acetylcholine receptor from Torpedo marmorata was digested using papain and the reaction 
products separated by SDS gel electrophoresis and characterised by immunoblotting using labelled a-bunga- 
rotoxin, polyclonal antibodies to synthetic peptides and monoclonal antibodies to the main immunogenic 
region (MIR). Using this approach, it was possible to show that the MIR is located N-terminal to all or 
part of peptide 151-169 (peptide Pl) of the a-chain and that papain cleaves the a-chain between Asn 141 
and peptide P 1. 
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1. INTRODUCTION 
The nicotinic acetylcholine receptor (nAChR) is 
the major autoantigen in the human autoimmune 
disease, myasthenia gravis (review [ 11). Autoanti- 
bodies to the receptor can be detected in the sera 
of about 90% of myasthenic patients [2]. Experi- 
mental models of the disease can be induced readily 
by immunisation with nAChR purified from elec- 
tric fish, such as the ray, Torpedo, or from mam- 
malian muscle (review [ 11). In both the natural and 
experimental systems, the majority of antibodies 
are directed against a relatively small region of the 
nAChR consisting of neighbouring epitopes, the 
main immunogenic region (MIR) [3-61. The recep- 
tor consists of 4 polypeptide chains (a, ,f3, y, 6), 
present in the ratio 2: 1: 1: 1 (review [7]). Anti- 
bodies to the MIR recognise the a-chain, which 
also carries the binding site for cholinergic ligands 
and specific probes, such as a-bungarotoxin. The 
sequences of all 4 chains of Torpedo nAChR have 
Abbreviations: PMSF, phenylmethanesulphonyl flue- 
ride; MBTA, (4-(N-maleimido)benzyl)trimethylammo- 
niumiodide, PBS phosphate-buffered saline (PI-I 7.1) 
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been determined by the use of cloning techniques 
(review [7]). Based on these data, it was initially 
proposed that the MIR might be contained in the 
region of residues 161-166 of the a-chain [8,9]. 
Using synthetic peptides, we have presented data 
suggesting that this is unlikely [lo], this subse- 
quently being confirmed by other workers [ll]. 
Using proteolytic cleavage and immunoblotting 
techniques, we are now able to localise the MIR to 
a region N-terminal to all or part of residues 
151-169 of the a-chain. 
2. MATERIALS AND METHODS 
2.1. Preparation of nAChR and ?rypsinked nAChR’ 
The nAChR was purified from the electric organs 
of T. marmorata as described [12], except that the 
detergent Triton X-100 was replaced by Emulpho- 
gene (polyoxyethylene 10 tridecyl ether, Sigma). 
‘Trypsinised nAChR’ was prepared as follows 
(all manipulations being carried out at 4°C unless 
stated otherwise). 100 g electric organ were homo- 
genised in 200 ml of 10 mM potassium phosphate 
buffer containing 10mM EDTA, 0.4M NaCl, 
0.1 mM PMSF, 0.01% NaN3, pH 7.4, for two 
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periods of I min using a Virtis 45 homogeniser. 
The homogenate was centrifuged at 6000 x g for 
10 min, and the supernatant recentrifuged at 
20 000 x g for 1 h. The pellet from the second cen- 
trifugation was resuspended in 6ml of 50mM 
potassium phosphate buffer containing 0.4 M 
NaCl, 0.01% NaN3, pH7.4 (buffer A) and the 
protein content determined. The concentration 
was adjusted to 5 mg/ml with buffer A and 
1 mg/ml trypsin (Sigma) added. The suspension 
was sonicated for 3 periods of 30s and incubated 
at 22°C for 30min. lOO/cl of 0.2M PMSF was 
added, the suspension resonicated, and then centri- 
fuged at 1~~ x g for 1 h. The pellet was ex- 
tracted with 30 ml of 10 mM potassium phosphate 
buffer containing 2% Emulphogene, 10mM ED- 
TA, 0.2mM PMSF, 0.01% NaN3, pH7.4, for 1 h 
and the extract processed normally by affinity 
chromatography. The a-chain of the purified ma- 
terial is found to lack the C-terminal 10 kDa unit 
as determined by direct and competitive radio- 
immunoassay or immunoblotting using antibodies 
to two synthetic peptides from this region (unpub- 
lished). 
2.2. Synthesis of peptides and preparation of 
ant isera 
Peptides Pl (residues 151-169) and P3 (residues 
426-437) of the a-chain were synthesised and used 
to raise antisera in rabbits as in [10,13]. 
2.3. rodinafion techniques 
Purified a-bungarotoxin f14] was iodinated to a 
specific activity of 900Ci/mmol as described in 
1151. 
Protein A (Sigma) was iodinated to a specific 
activity of 18 Ci/mg according to ]16]. 
2.4. Monoclonal antibody production 
The production and characterisation of the 
monoclonal antibodies used have been described 
[3-61. Culture supernatants were concentrated 
approx. 20-fold by precipitation with ,ammo~um 
sulphate, and then dialysed against PBS containing 
0.05% NaN3. 
2.5. ~roteo~ytic digestion 
nAChR or trypsinised nAChR at 1 mg/ml in 
10 mM potassium phosphate buffer containing 
0.5 M NaCl, pH 7.4, was mixed with an equal 
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volume of 0.25 M Tris-HCl buffer containing 1% 
(w/v) SDS, 20% (v/v) glycerol, pH 6.8, and boiled 
for 2 min. Papain (type III, Sigma, 1 mglml in 
water) was then added to give an enzyme-substrate 
ratio of 1: 5. Digestion was performed at 25°C for 
45 min. The mixture was then boiled for 2 min to 
stop the reaction. SDS and mer~aptoethanol were 
added to final concentrations of 1 and 2.5%, 
respectively, and the mixture again boiled. Control 
samples were treated identically except that papain 
was omitted. 
2.6. Electrophoresis and blotting methods 
Electrophoresis was performed using the SDS- 
polyacrylamide system of Laemmli as described in 
[ 131. Typically, 1%2Opg protein was applied per 
lane of a 12.5% gel and electrophoresis was per- 
formed at 40-100 V until the tracking dye was near 
the bottom of the gel. The gel was then soaked in 
25 mM Tris, 192 mM glycine, 0.1% SDS, 20% 
(v/v) methanol (buffer B) for 20min. Electro- 
phoretic transfer to 0.45pm nitrocellulose was car- 
ried out in buffer B at 400mA for 3 h at 4°C. All 
subsequent operations were performed at 22OC. 
The nitro~ellulose sheet or strips were incubated 
for 1 h in PBS containing 0.05% Tween 20, pH 7.1 
(buffer C), in plastic bags or tubes. Appropriate 
volumes of antisera or monoclonal antibody sam- 
ples diluted l/100 in buffer C were added and in- 
cubated for 1 h. Two washing steps of 20 min using 
buffer C were performed. In the case of mono- 
clonal antibodies, an equal volume of a rabbit anti- 
rat igG diluted l/100 in buffer C was then added, 
incubated for 1 h and washed as above. Radio- 
labelled protein A (2 vols with respect to antisera, 
final concentration 24 ng/ml in buffer C) was 
added, incubated for I h and again washed twice. 
In the case of cu-bungarotoxin, the labelled toxin 
(2.5 nM in buffer C) was added and incubated for 
2.75 h before two washes as above. Dried blots 
were then exposed at -7O’C using Kodak X-Omat 
S film and one intensifying screen. 
2.7. Co~canava~in A absorption 
After digestion, the material was incubated with 
0.6 vol. of packed concanavalin A-Sepharose 
(Pharmacia) for 1 h at 22*C. After centrifugation, 
the supernatant was adjusted to 1% SDS and 2.5% 
mercaptoethanol and processed for electrophore- 
sis. 
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3. RESULTS 
3.1. Specificity of binding 
As shown in fig, 1, monoclonal antibodies to the 
MIR, polyclonal antisera to synthetic peptides Pl 
and P3, and labelled cu-bungarotoxin bound only 
to the a-chain of the receptor. 
3.2. Papain digestion products 
After papain digestion, antibodies to the MIR 
bound to a major digestion product of 19 kDa 
(fig. 1). Variable amounts of material at lo-13 kDa, 
-27K 
-13K 
-FfKPdT 
Fig.1. Blots of nAChR and papain-treated nAChR. Di- Fig.2, Co~canavalin A absorption of papain digestion 
gestion, electrophoresis and transfer were performed as products. Digestion, eIectrophoresis and transfer were 
described in section 2. Lanes 1, 3, 5 and 7 contain un- performed aa described in section 2. Lanes 1, 3 and 5 
digested receptor, lanes 2, 4. 6 and 8 papain-digested contain non-absorbed digestion products, lanes 2,4 and 
receptor. Blotting was performed with anti-MIR mono- 6 the supernatants from the concanavalin A absorption 
clonal antibody 35 (lanes 1, 2), with antisera to peptide stage. Strips were blotted with anti-MIR antibody 35 
Pl {lanes 3,4) or peptide P3 (lanes 5,6) or with labelled (lanes 1, 2), antiserum to peptide PI (lanes 3, 4) and 
a-bungarotoxin (lanes 7, 8). antiserum to peptide P3 (lanes 5, 6). 
reactive with the anti-MIR antibodies, were also 
observed, Identical results were obtained with 6 
other monocional antibodies to the MIR (mAbs 6, 
47, SO, 71, 198, 203; not shown). In contrast, LY- 
bungarotoxin and antibodies to peptides PI and 
P3 bound to a major digestion product of 27 kDa 
and to a minor product of approx. 36 kDa (fig.1). 
Toxin and antibodies to peptide Pl also bound to 
a minor component of approx. 24 kDa. 
3.3. Relative positions of the peptide~ in the 
LY- chain 
(i) As noted above, material reactive with anti- 
bodies to the C-terminal peptide P3 comigrated 
with the material reactive with antibodies to PI 
(fig. 1). 
t 
-19K 
+-FRQNT 
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Fig.3. Papain digestion of trypsinised receptor. Diges- 
tion, electrophoresis and transfer were performed as 
described in section 2. The samples applied were un- 
treated nAChR (lanes 1, S), papain-digested nAChR 
(lanes 2, 6), untreated trypsinised nAChR (lanes 3, 7) 
and papain-treated trypsinised receptor (lanes 4, 8). 
Lanes 1-4 were developed using anti-MIR monocIona1 
antibody 35, lanes 5-8 using antipeptide antiserum 
specific for peptide Pl. Band 1 is the a-chain of the 
nAChR. Band 2, a doublet, is the a-chain of trypsinised 
nAChR. 
(ii) Absorption with concanavalin A, which 
binds to carbohydrate linked to Asn 141 of the LY- 
chain, removed completely the peptide containing 
the MIR, but not the Pl or P3 containing peptide 
(fig.2). The material reactive with toxin was also 
not removed (not shown). 
(iii) Digestion of trypsinised nAChR, which 
lacks the C-terminal 1OkDa unit, produced an 
identical product of 19 kDa reactive with anti-MIR 
antibodies (band 4, fig.3) whereas the 27 kDa frag- 
ment reactive with anti-P1 antibodies (band 3, 
fig.3) was replaced by a fragment of 17 kDa (band 
5, fig.3). 
4. DISCUSSION 
Previous experiments [17] have shown that 
papain cleavage of purified a-chain generates a 
fragment of 27 kDa which is labelled by the site- 
directed affinity ligand MBTA and fragments of 17 
and 10 kDa which contain carbohydrate and bind 
antibodies to the MIR. Similarly, Tzartos and 
Changeux [l&19] have shown that, whereas re- 
natured whole chain can bind both toxin and some 
antibodies to the MIR, the 27 kDa fragment, after 
renaturation, could bind only toxin. However, fur- 
ther characterisation of these peptides was not 
possible because of a lack of suitable markers. The 
ability to synthesise peptides chosen from the pub- 
lished sequence now allows us to raise antibodies 
to specific sites as markers to characterise these 
products. 
Using polyclonal antisera to synthetic defined 
peptides and monoclonal antibodies to the MIR, 
we have been able to show that the MIR and con- 
canavalin A reactive carbohydrate reside on the 
same peptide (fig.2) and that the ac-bungarotoxin- 
binding site is carried on a larger peptide con- 
taining peptides Pl (151-169) and the C-terminal 
peptide P3 (425-437). As only carbohydrate 
groups linked to asparagine are known to react 
with concanavalin A ]20] and as the only suitable 
asparagine group of the a-chain is Asn 141, it fol- 
lows that this residue is carried on the smaller 
19 kDa peptide. Since residues 15 1-437 are present 
in the 27 kDa fragment and residue 141 in the 
19 kDa fragment, the MIR can be localised N-ter- 
minal to peptide Pl. This is confirmed by papain 
cleavage of trypsinised nAChR (lacking the C-ter- 
minal 10 kDa unit). As expected, the N-terminal 
MIR containing peptide still has a molecular mass 
of 19 kDa, but the C-terminal peptide containing 
Pl changes its molecular mass by approx. 10 kDa. 
The MIR can thus be localised N-terminal to all or 
part of peptide P 1 (15 1 - 169) and papain cleavage 
occurs between Asn 141 and peptide PI. 
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